In Hypertension (high blood pressure) AMZEL-EL 5MG/2.5MG TABLET relaxes the blood vessels so that blood can flow more easily around your body. This lowers your blood pressure and reduces your risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should take it regularly as prescribed for this medicine to be most effective, even if you feel better.
It is unsafe to consume alcohol with AMZEL
Pregnancy : CONSULT YOUR DOCTOR
EL 5MG/2.5MG TABLET is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life
Breast feeding : SAFE IF PRESCRIBED
EL 5MG/2.5MG TABLET is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
AMZEL
EL 5MG/2.5MG TABLET may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
AMZEL
EL 5MG/2.5MG TABLET may be needed. Please consult your doctor. Regular monitoring of blood pressure, kidney function test, and potassium levels is recommended while you are taking this medicine.
AMZEL
EL 5MG/2.5MG TABLET may be needed. Please consult your doctor. Inform your doctor if you experience fatigue, develop yellowing of the skin and eyes or white stools while taking this medicine.
If you miss a dose of AMZEL-EL 5MG/2.5MG TABLET, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Cadila Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)